Pharmacy & Medication Management
Pharmacy and medication-management pathways connect prescriptions, dispensing, refills, stock constraints, substitutions, allergies, interactions, reconciliation, and adherence.
Why it matters
Medication safety is a major patient-safety priority because prescribing, dispensing, refills, substitutions, allergies, interactions, stockouts, and adherence often sit in different workflows. WHO Medication Without Harm guidance emphasizes safer systems, transitions, high-risk medicines, polypharmacy, and patient involvement.
InBasket AI keeps this care-domain pathway connected to one continuous patient record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.
Designed with reference to recognized global, national, and clinical standards
This care area is designed with reference to a standards ecosystem, including global guidance, national protocols, specialty-society recommendations, interoperability standards, and programme reporting requirements where applicable:
- WHO Medication Without Harm global patient-safety challenge
- WHO Model List of Essential Medicines
- FIP / national pharmacy practice, dispensing, and medication-counselling standards where adopted
- National formulary, essential medicines list, stock, substitution, and pharmacovigilance requirements
- National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
- HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted
Standards sources
These sources substantiate the standards named above. Implementation-specific national protocols are selected from official national or regional authorities during deployment.
- World Health Organization guidelines and publications
- Official national Ministry of Health protocols for the implementation setting — Implementation-specific: selected from the official national or regional authority during deployment.
- International Pharmaceutical Federation
- HL7 FHIR
- WHO ICD classifications
- LOINC
- SNOMED CT
Evidence sources
See it in your setting.
Start a guided pilot conversation — we’ll map the care setting, deployment model, and first workflows together.
Start a pilot conversation